Impact Factor
2.67
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.90
125 total citations
h5-index
12
h5 depth signal
Cited share
52.1%
37 of 71
Total citations
125
Citation footprint
Metric signal
1.92
External metric anchor
Self-citation
7.2%
9 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
India
88
Russia
46
Spain
36
Nigeria
29
United States
22
Citing Fields of Research
Pharmacology & Toxicology
164
Genetics & Genomics
67
Cancer Drugs
42
Phytochemicals
39
Cardiology
35
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
444
Articles tracked across the journal lifetime
Indexed publication set
71
37 cited publications
Last 12 months
35
3.2 publications/month
Open access share
60.0%
21 OA publications in the last year
Leading citing country
India
88 citing publications
Leading citing field
Pharmacology & Toxicology
164 citing publications
Latest tracked publication
7 October 2026
10 recent records available
Coverage & Indexing History
v30issue 1, 2015-
v30issue 1, 2015-
Research Focus & Classification
Indexed Subjects
Pharmacology & Toxicology
Phytochemicals
Genetics & Genomics
Allergies
Diabetes
Cancer, Autophagy & Apoptosis
Issuing & Sponsoring Bodies
issuing body
European Society of Pharmacogenomics and Personalised Therapy
Broad Categories
Pharmacology
Genetics & Genomics
Phytochemicals
Pharmacology & Toxicology
Cardiology
Urology
Molecular & Cellular Toxicology
Endocrinology & Metabolism
MeSH Descriptors
Pharmacogenetics
Pharmacology
Precision Medicine
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1515/dmpt-2026-0030
Open DOI
CYP2C9 and VKORC1 variants and warfarin response in Kazakh patients following cardiac surgery
Objectives: To evaluate the association between CYP2C9 and VKORC1 polymorphisms and warfarin therapy outcomes in Kazakh patients following cardiac surgery, with a focus on dose requirements, INR stabilisation and bleeding complications. ...
02
DOI 10.1515/dmpt-2026-0047
Open DOI
Leaders in pharmacogenetics: Leif Bertilsson
03
DOI 10.1515/dmpt-2026-0021
Open DOI
Safinamide dual molecular mechanisms: sodium channel and glutamate modulation as a translational rationale for neuropathic pain – A narrative review
Introduction: Neuropathic pain is a chronic and debilitating condition characterized by maladaptive changes in peripheral and central nervous system pathways. It is driven by abnormal neuronal excitability and excitatory neurotransmissio...
04
DOI 10.1515/dmpt-2026-frontmatter3
Open DOI
Frontmatter
05
06
DOI 10.1515/dmpt-2026-0022
Open DOI
Association of HTR2A (rs6313) gene polymorphism with autism spectrum disorder in Jordanian children: a case-control study
Objectives: Autism spectrum disorder (ASD) is a complex neurodevelopmental condition with a significant genetic component, often linked to disruptions in the serotonergic system. The HTR2A gene, specifically the rs6313 (102T>C) polymorph...
07
DOI 10.1515/dmpt-2026-0018
Open DOI
Assessment of the impact of valproic acid co-administration on clozapine plasma concentrations in Tunisian patients
Objectives: Reports on drug-drug interactions between valproic acid (VPA) and clozapine (CLZ) are very inconsistent. Previous reports demonstrate that VPA may exhibit either inhibitory or inductive effects or have no effect on CLZ pharma...
08
DOI 10.1515/dmpt-2025-0096
Open DOI
Withania somnifera ameliorates endoplasmic reticulum stress in human hepatocellular carcinoma HepG2 cells
Objectives: Endoplasmic reticular (ER) stress plays an important role in gene modulation and the consequent release of several inflammatory mediators i.e., cytokines and proteases, key players associated with systemic-induced inflammatio...
09
DOI 10.1515/dmpt-2025-0087
Open DOI
Impact of TNF-alpha -308 G/A polymorphism on response to TNF inhibitors in Tunisian patients with inflammatory rheumatic diseases
Objectives: To evaluate the impact of the TNF-α promoter SNP -308G/A on therapeutic response, serum drug levels, and immunogenicity of TNF inhibitors in chronic inflammatory rheumatic diseases. Methods: This cross-sectional, multicentric...
10
DOI 10.1515/dmpt-2026-0006
Open DOI
MicroRNA sequencing reveals modulation of neurodegenerative miRNAs by Withania somnifera in human neuroblastoma SK-N-SH cells
Objectives: Withania somnifera (WS) is known for its adaptogenic benefits; however, its beneficial effects in neurodegenerative diseases have not been fully explored. MicroRNAs (miRNAs) are small noncoding RNAs whose role(s) in modulatin...
Bibliographical & Catalog Notes
Also issued online.